KLSE:SUNMED Income Statement

Financials in millions MYR. Fiscal year is January - December.

Millions MYR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	2,092	1,852	1,457	1,065
Revenue Growth (YoY)	-	27.15%	36.83%	-
Cost of Revenue	798.63	701.18	556.85	403.45
Gross Profit	1,294	1,151	900.04	661.33
Selling, General & Admin	847.6	699.7	529.6	388.79
Other Operating Expenses	147.85	116.16	110.04	78.09
Operating Expenses	1,003	823.94	643.05	466.76
Operating Income	290.96	327.34	256.99	194.57
Interest Expense	-56.31	-46.2	-19.9	-15.14
Interest & Investment Income	29.06	17.34	7.04	7.42
Currency Exchange Gain (Loss)	5.41	1.86	0	-
Other Non Operating Income (Expenses)	-2.02	-1.48	-1.52	0.02
EBT Excluding Unusual Items	267.1	298.85	242.62	186.87
Other Unusual Items	5.03	-	0.17	57.53
Pretax Income	272.13	298.85	242.78	244.4
Income Tax Expense	53.89	41.34	61.15	34.49
Earnings From Continuing Operations	218.24	257.51	181.63	209.91
Minority Interest in Earnings	-0.01	-0.01	-0.01	-0.01
Net Income	218.23	257.5	181.63	209.9
Net Income to Common	218.23	257.5	181.63	209.9
Net Income Growth	-	41.78%	-13.47%	-
Shares Outstanding (Basic)	9,954	9,737	9,570	8,932
Shares Outstanding (Diluted)	10,925	10,925	10,925	10,925
EPS (Basic)	0.02	0.03	0.02	0.02
EPS (Diluted)	0.02	0.02	0.02	0.02
EPS Growth	-	42.17%	-13.55%	-
Free Cash Flow	-153.14	-110.66	-589.79	-421.58
Free Cash Flow Per Share	-0.01	-0.01	-0.05	-0.04
Gross Margin	61.83%	62.15%	61.78%	62.11%
Operating Margin	13.91%	17.67%	17.64%	18.27%
Profit Margin	10.43%	13.90%	12.47%	19.71%
Free Cash Flow Margin	-7.32%	-5.97%	-40.48%	-39.59%
EBITDA	452.33	452.48	354.64	262.25
EBITDA Margin	21.62%	24.43%	24.34%	24.63%
D&A For EBITDA	161.37	125.15	97.64	67.68
EBIT	290.96	327.34	256.99	194.57
EBIT Margin	13.91%	17.67%	17.64%	18.27%
Effective Tax Rate	19.80%	13.83%	25.19%	14.11%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.